glp-1 supply shortage news november 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo How to Survive the GLP-1

Convenience and Long-Acting Effects Administered as a once-weekly injection, easy to incorporate into a patients routine

In August, the company announced people who had obesity or were overweight without diabetes lost 12% of their body weight on average with the orforglipron pill after 72 weeks in a late-stage trial

Care 27 RittirschD.Huber-LangM

Lustig RH: The role of insulin suppression in the treatment of obesity

I know theres a lot to unpack here, but I think my real questions are, how do I have confidence in a choice I believe is right for me, while anticipating a reaction from others that feels negative and judgy